NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...

ATLANTA – NxStage Medical Inc. introduced a new patient outreach campaign at the Annual Dialysis Conference, called NxStage Plus One. The campaign aims to increase awareness of home hemodialysis ...

It's been an up-and-down year for NxStage Medical (NASDAQ: NXTM) shareholders. The medical technology company's stock dropped over 35% by mid-February only to rebound strongly over the past three ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

The home-dialysis specialist company ended 2014 on a positive note and has high hopes for 2015. Coming into Thursday morning's fourth-quarter report, NxStage investors had high hopes that the company ...

- "The more I realize how things have changed for the better, the more amazed I am," said Maria Jimenez, a former NxStage patient. "Switching from in-center to home hemodialysis with NxStage System ...

LAWRENCE, Mass., Feb. 19, 2013 /PRNewswire/ -- NxStage(R) Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced CE Mark approval for nocturnal home hemodialysis with ...

NxStage Medical, Inc.NXTM announced that its Nx2me Connected Health (remote patient management system) reduces home hemodialysis technique failure or conversion to in-center hemodialysis by 29%.

The medical technology company inches closer to profitability thanks primarily to improving System One sales. NxStage reported its second-quarter results before the markets opened on Thursday. Did ...